Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stephanie Vrede"'
Autor:
Petra Vinklerová, Petra Ovesná, Jitka Hausnerová, Johanna M. A. Pijnenborg, Peter J. F. Lucas, Casper Reijnen, Stephanie Vrede, Vít Weinberger
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionAmong industrialized countries, endometrial cancer is a common malignancy with generally an excellent outcome. To personalize medicine, we ideally compile as much information as possible concerning patient prognosis prior to effecting an
Externí odkaz:
https://doaj.org/article/6f2e7615f68f4c819aee78bed95cbfab
Autor:
Stephanie Vrede, Willem Jan Weelden, Hans Bulten, Jutta Huvila, Xavier Matias-Guiu, Antonio Gil-Moreno, Jasmin Asberger, Sanne Sweegers, Louis Putten, Heidi Küsters-Vandevelde, Astrid Eijkelenboom, Casper Reijnen, Eva Colas, Vit Weinberger, Marc Snijders, Roy Kruitwagen, Johanna Pijnenborg
Publikováno v:
Featured Printed Posters (Poster Rounds with the Professors).
Autor:
Antonella Ravaggi, Davide Capoferri, Laura Ardighieri, Iacopo Ghini, Federico Ferrari, Chiara Romani, Mattia Bugatti, Laura Zanotti, Stephanie Vrede, Germana Tognon, Johanna M. A. Pijnenborg, Enrico Sartori, Stefano Calza, Eliana Bignotti, Franco Odicino
Publikováno v:
Cancers, 14
Cancers; Volume 14; Issue 21; Pages: 5429
Cancers, 14, 21
Cancers; Volume 14; Issue 21; Pages: 5429
Cancers, 14, 21
Contains fulltext : 287744.pdf (Publisher’s version ) (Open Access) Histopathologic assessment of high-risk endometrial cancer (EC) suffers from intersubject variability and poor reproducibility. The pragmatic classification in four molecular subgr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06fda58e3f824f51de18ec3f5b86eed5
http://hdl.handle.net/2066/287744
http://hdl.handle.net/2066/287744
Autor:
Willem Jan van Weelden, Stephanie Vrede, Louis van der Putten, Hans Bulten, Marc Snijders, Sanne Sweegers, Andrea Romano, Astrid Eijkelenboom, Anja van de Stolpe, Johanna Pijnenborg
Publikováno v:
Cancer Research. 82:1962-1962
Introduction: Immunohistochemical expression (IHC) of estrogen receptor (ER) and progesterone receptor (PR) are biomarkers for prognosis and response to hormonal therapy in endometrial cancer (EC). However, the presence of ER/PR is not inherently ref